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Sunday, February 3, 2013 159aThe N-terminal domains of cMyBPC inhibit the activation of the steady state
ATPase myosin by f-actin. However, in the presence of native cardiac thin fil-
aments.the N-terminal domains C1C2 and C0C2 of mouse and human cMyBPC
produce biphasic effects on the steady state ATP hydrolysis of cardiac myosin-
S1. That is, ATPase is activated at low ratios of cMyBPC-N-terminal domain to
thin filament and is inhibited by higher ratios similar to the effects observed
with f-actin. These data suggest that low ratios of cMyBPC N-terminal domains
activate thin filaments in a mechanism similar to that of rigor myosin-S1 but
higher ratios inhibit the ATPase rate by competing with myosin-S1-ADP-Pi
binding to actin and thin filaments. Effects also appear species-dependent since
the C0C1 domains of human cMyBPC produce similar effects as C1C2 and
C0C2 on ATPase in the presence of thin filaments, but mouse C0C1 does
not produce significant activation.Cellular Pathways & Networks
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In the United States, 30 billion dosages of non-steroidal anti-inflammatory
drugs (NSAIDs) are consumed annually to relieve fever, pain, and inflamma-
tion. While NSAIDs are generally considered safe, some including meclofena-
mate sodium (MS) have been reported to increase the risk of cardiovascular
events. Because the impairment of the proteasome, a multi-catalytic complex
that breaks down 60-80% of proteins in the mammalian cell, has been associ-
ated with heart failure, the effects of MS on the proteasome activity were inves-
tigated. MS at 30 micromolar inhibited purified 20S proteasome activity by
40% and 26S proteasome activity in H9c2 rat cardiac cells and mouse heart tis-
sue lysates by 30-40%. MS was also shown to decrease the cell proliferation
rate and muscle differentiation of H9c2 cells. To investigate the mechanism
of action of MS, H9c2 cells were treated with MS and the fluorescent protea-
some inhibitor MV151 that bind to beta 1, beta 2, and beta 5 enzymatic sites
of the proteasome. MS, in a concentration-dependent manner, competed with
MV151, indicating that MS may exert its inhibitory effects by directly binding
to the proteasome’s active sites. At the mRNA level, 100 micromolar MS
increased the expression of genes involved in stress response and antioxidant
metabolism, such as glutathione S-transferase omega. When H9c2 cells were
pre-treated with 3 millimolar tempol, a membrane-permeable radical scaven-
ger, then with 200 micromolar MS for 24hr, tempol recovered the beta 5 26S
proteasome activity by 20-40%. However, tempol and other antioxidants
such as N-acetyl cysteine and L-ascorbic acid (vitamin C) alone inhibited the
proteasome activity by 20-50%. MS does not increase the caspase-3 activity
at 10-30 micromolar concentrations, suggesting that apoptosis is not involved
in the decreased cell viability in MS treated H9c2 cells.
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Spinal muscular atrophy (SMA) - the most common genetic cause of death in
infancy - is a motor neuron disease caused by reduced expression of the sur-
vival motor neuron (SMN) protein. It is currently unknown why reduction in
SMN, leads to selective motor deficits and muscle weakness. Using the
SMA-D7 mouse model, we have previously reported that the sensory-motor
circuit is dysfunctional early in the disease and precedes any motor neuron
loss. Motor neurons in the L1 segment, innervating proximal muscles, are
abnormally hyperexcitable and more affected than L5 motor neurons, innervat-
ing distal hindlimbs early after birth. To test whether this hyperexcitability is
either due to synaptic dysfunction or SMN deficiency per se in motor neurons,
we recorded intracellularly from L5 motor neurons at a time (P4) when there
was no significant functional synaptic impairment.
We employed the in vitro intact spinal cord preparation. Whole-cell patch
clamp recordings revealed that the intrinsic properties of SMA L5 motor neu-
rons were not significantly different than wild type (WT) age-matched counter-
parts. The passive membrane property of input resistance was on average
72.7518.1 MU in WT (n=10) and 53.9521.7 MU in SMA (n=5) motor
neurons. Similarly, the time constant was 1.950.5 ms in WT and 2.0 5
0.7 ms in SMA. Furthermore, the active membrane properties of: Rheobase
(WT: 0.750.2 nA; SMA:0.850.2 nA), Vthreshold (WT: 31.653.7 mV;SMA: 33.652.6 mV), action potential amplitude (WT: 72.855.2 mV;
SMA: 73.253.6 mV) and rate of rise (WT: 48.856.2 mV/ms; SMA:
40.2510.0 mV/ms) were not significantly different (t-test).
These results indicate that the intrinsic hyperexcitability of SMA motor neu-
rons stems from dysfunctional spinal circuits and raise the possibility that
SMA may be a disease of motor circuits acting via non-cell autonomous
mechanisms.
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In type 2 diabetes (T2DM), hyperglycemia (HG) and increased sympathetic
drive may alter mitochondria energetic/redox properties, decreasing the organ-
elle’s functionality. These perturbations sustain basal low-cardiac performance
and limited exercise capacity. We have recently reported that improving the re-
dox/energetic balance of T2DM (db/db) murine cardiomyocytes/hearts with
GSH or palmitate (Palm) preserves contractile performance under high-
energy demand imposed by combined HG and b-adrenergic stimulation. To
further understanding the metabolic basis of Palm salutary action, we first ap-
plied metabolomics to Langendorff-perfused T2DMmurine hearts subjected to
energy/redox stress conditions. In the absence of Palm, HG activates polyol
pathways (sorbitol, glycerol, xylitol) triggering flux limitations in glycolytic
and pentose phosphate (PP) pathways. The metabolite profile under Palm
reveals that this fatty acid (FA) reverses the detrimental action of HG by de-
creasing polyol accumulation and increasing flux through PP, glycolytic, and
beta-oxidation pathways, with a concomitant improvement in cardiomyocyte
contraction. To confirm this observation, next we inhibited the polyol or acti-
vated the PP pathways. Preincubating HGþISO-treated myocytes with the
aldose reductase inhibitor Zopolrestat (1mM) improved the adrenergic inotropic
response, in parallel with the re-activation of glycolysis and oxidative phos-
phorylation. These same effects were observed pre-incubating HGþISO chal-
lenged myocytes with the activator of transketolase benfotiamine (50mM).
Present data indicate that in T2DM hearts HG/ISO regimen unveils a status
of mitochondrial dysfunction that favors adverse intracellular redox/energetic
conditions and a metabolic remodeling that implies a glucose shunt to polyol
pathways and an apparent blockade of glycolysis. These changes appear to
be relieved by the exogenous administration of the FA Palm.
814-Pos Board B583
Intracellular Transport Control of Signaling Networks
Jose M.G. Vilar1, Leonor Saiz2.
1Biophysics Unit (CSIC-UPV/EHU) and Department of Biochemistry and
Molecular Biology, University of the Basque Country, Bilbao, Spain,
2University of California, Davis, Davis, CA, USA.
Many cellular networks rely on the regulated transport of their components to
transduce extracellular information into precise intracellular signals. The dy-
namics of these networks is typically described in terms of compartmentalized
chemical reactions. There are many important situations, however, in which the
properties of the compartments change continuously in a way that cannot nat-
urally be described by chemical reactions. Here, we develop an approach based
on transport along a trafficking coordinate to precisely describe these processes
and we apply it explicitly to the TGF-b signal transduction network, which
plays a fundamental role in many diseases and cellular processes. The results
of this newly introduced approach accurately capture the distinct TGF-b signal-
ing dynamics of cells with and without cancerous backgrounds and provide an
avenue to predict the effects of chemical perturbations in a way that closely re-
capitulates the observed cellular behavior.
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Multistability in biological systems is an important concept that is believed to
underlie phenotypic diversity in microorganisms as well as tissue differentia-
tion at the multicellular level. Despite the importance of the subject, under-
standing of this phenomenon derives from a very small group of extensively
studied examples. We are working to identify novel biological networks that
exhibit bistability in nutrient uptake. In particular, we are investigating uptake
